Evidence map›Paper›PMID 33900120›Full record

ArticleCell transplantation

Ginsenoside Rb1 Alleviates Lipopolysaccharide-Induced Inflammatory Injury by Downregulating miR-222 in WI-38 Cells.

Erhu Wei, Xiao Fang, Peisheng Jia, Mingxia Li, Peina Jin, Fengyan Li, Huaili Wang, Dan Gao

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ginsenosides fromInternational journal of molecular sciences · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Erhu WeiDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiao FangDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Peisheng JiaDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mingxia LiDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Peina JinDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fengyan LiDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Huaili WangDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dan GaoDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0003-0961-7800
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumonia is a serious respiratory tract infection disease in children, which threatens to the health or life of children patients. Ginsenoside Rb1 (Rb1) is a principle active ingredient extracted from the root of

Indexed as

Cell LineDown-RegulationGinsenosidesHumansInflammationLipopolysaccharidesMicroRNAsPanaxTransfectionginsenoside Rb1GinsenosidesLipopolysaccharidesMicroRNAsMIR222, humanginsenoside Rb1inflammatory injurymiR-222NF-kB pathwaypneumonia

Identifiers

PMID33900120
PMCPMC8085372
OpenAlexW3157961019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.